Search

Freenos SR

Freenos SR

loratadine + pseudoephedrine

Manufacturer:

PT Ferron

Distributor:

Hind Wing
Concise Prescribing Info
Contents
Per IR pellet Pseudoephedrine HCl 60 mg, loratadine 5 mg. Per SR pellet Pseudoephedrine HCl 60 mg
Indications/Uses
Relief of nasal & ocular symptoms of upper resp mucosal congestion eg, in allergic rhinitis.
Click to view Freenos SR detailed prescribing information
Dosage/Direction for Use
Adult & childn ≥12 yr 1 cap bd.
Click to view Freenos SR detailed prescribing information
Overdosage
View Freenos SR overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to loratadine or pseudoephedrine, or idiosyncrasy to their components including metabolite descarboethoxy-loratadine, to adrenergic agents or to other drugs of similar chemical structure. Concomitant use w/ MAOI or w/in 14 days of discontinuing such treatment. Patients w/ narrow angle glaucoma, urinary retention, HTN, severe CAD & hyperthyroidism.
Click to view Freenos SR detailed prescribing information
Special Precautions
Limit use to 3 mth. Not recommended during pregnancy & lactation. Pseudoephedrine: Patients w/ stenosing peptic ulcer, pyloroduodenal obstruction, prostatic hypertrophy or bladder neck obstruction, CV disease, increased IOP or DM; patients receiving digitalis. Risk of CNS stimulation, excitability, convulsions &/or CV collapse w/ accompanying hypotension; acute generalized exanthematous pustulosis. Potential for abuse & tolerance. Risk of depression following rapid w/drawal. Elderly ≥60 yr. Loratadine: Patients w/ severe liver impairment.
Click to view Freenos SR detailed prescribing information
Adverse Reactions
Dizziness, dry mouth, fatigue, headache, insomnia, nervousness, sedation; CNS stimulation, muscular weakness, chest tightness, syncope.
Click to view Freenos SR detailed prescribing information
Drug Interactions
Pseudoephedrine: Hypertensive reactions (including hypertensive crises) w/ MAOIs. Reduced antihypertensive effects of methyldopa, mecamylamine, reserpine, veratrum alkaloids. Potential interaction w/ β-adrenergic blockers. Increased absorption rate w/ antacids. Decreased absorption rate w/ kaolin. Increased ectopic pacemaker activity w/ digitalis. Do not take concomitantly w/ furazolidone. Combined CV effects w/ other sympathomimetic amines. Loratadine: Increased plasma conc w/ ketoconazole, erythromycin, cimetidine. Caution w/ concomitant use of other drugs known to inhibit hepatic metabolism. Discontinue approx 48 hr prior to skin testing procedures.
Click to view Freenos SR detailed prescribing information
Storage
View Freenos SR storage conditions for details to ensure optimal shelf-life.
Description
View Freenos SR description for details of the chemical structure and excipients (inactive components).
Action
View Freenos SR mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Cough & Cold Preparations
ATC Classification
R01BA02 - pseudoephedrine ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic use.
Presentation/Packing
Form
Freenos SR cap
Packing/Price
50's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in